Rivastigmine Tartrate

Product NDC
0781-2614
11-digit product format
007812614
Labeler code
0781
Product ID
0781-2614_3375f1a6-a261-4c5c-81ee-674a11cefaf8
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
rivastigmine tartrate
Dosage form
CAPSULE
Route
ORAL
Labeler
Sandoz Inc
Application
NDA020823
Marketing category
NDA AUTHORIZED GENERIC
Marketing start
2000-04-30
Marketing end
0000-00-00
Substance
RIVASTIGMINE TARTRATE
Active strength
2 mg/1
Pharmacologic classes
Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
NDC exclude flag
E
Listing certified through
2018-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
0781-2614-602020-10-07C16284748780-19d75b9d0-7c3c-f424-e053-dadaa90a57ce4e775022-4b71-4716-bc9b-f374edaf9edb
0781-2614-602020-01-31C16284748780-19d75b9d0-7c3c-f424-e053-dadaa90a57ce4e775022-4b71-4716-bc9b-f374edaf9edb

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0781-2614-13EA - Each0781-2614d10eb79e-1717-497d-adc5-2f5574d17d5412012-07-24
0781-2614-60EA - Each0781-26145029b4ea-a654-48c2-9c86-fdb8f03f324c12012-07-24